Indeed, in breast cancers, contrary to what has been reported in melanomas32, ALDH inhibition alone is not sufficient to explain the anti-CSC effect of NIF, but it rather depends on the inhibition of STAT3-FA signaling coupled with the generation of DNA ICLs. The gene discussed is STAT3; the disease is breast carcinoma.